(Q45856471)

17 December 2017

title

NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts (English)

1 reference

17 December 2017

0 references

2

1 reference

17 December 2017

author name string

H Shimizu

1

1 reference

17 December 2017

I Tsukamoto

3

1 reference

17 December 2017

S Morita

4

1 reference

17 December 2017

Y Kunugiza

5

1 reference

17 December 2017

T Tomita

6

1 reference

17 December 2017

H Yoshikawa

7

1 reference

17 December 2017

Y Kaneda

8

1 reference

17 December 2017

T Ogihara

9

1 reference

17 December 2017

R Morishita

10

1 reference

17 December 2017

publication date

2 March 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

933-941

1 reference

17 December 2017

Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Modulation of osteoclast differentiation by local factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Impaired expression of noncollagenous bone matrix protein mRNAs during fracture healing in ascorbic acid-deficient rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Bone resorption by isolated osteoclasts in living versus devitalized bone: differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

The effect of substrate composition and condition on resorption by isolated osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

The determination of hydroxyproline in urine hydrolysates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Inhibition of parathyroid gland activity by hypermagnesemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302711

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302711

1 reference

17 December 2017

Dimensions Publication ID

1006881919

0 references

1 reference

17 December 2017